Literature DB >> 8253728

Inefficient degradation of triglyceride-rich lipoprotein by HepG2 cells is due to a retarded transport to the lysosomal compartment.

P Lombardi1, M Mulder, H van der Boom, R R Frants, L M Havekes.   

Abstract

Binding studies at 37 degrees C showed that lipoprotein lipase-treated very low density lipoproteins (LPL-VLDL) and very low density lipoproteins (VLDL), once taken up via the low density lipoprotein (LDL) receptor, are poorly degraded by HepG2 cells as compared with LDL. Determination of the initial endocytotic rate for LPL-VLDL and VLDL as compared to LDL shows that LPL-VLDL and VLDL are internalized at a similar rate as LDL. Incubation of cells with labeled LDL, LPL-VLDL, and VLDL at 18 degrees C for 4.5 h resulted in the accumulation of these particles in the early endosomes, without subsequent transport to the lysosomes and degradation. After washing the cells and a temperature shift to 37 degrees C, the labeled LDL present in the early endosomes is transported to the lysosomal compartment almost completely within 15 min. Strikingly, for LPL-VLDL and for VLDL, only about 50% or less of the label was moved to the lysosomal compartment within 45 min. However, once present in the lysosomes, VLDL and LPL-VLDL are degraded about 1.6-fold more rapidly than LDL. Retroendocytosis accounts for less than 10% of the internalized LDL, whereas a higher rate of retroendocytosis, up to 20 and 40%, respectively, was observed for LPL-VLDL and VLDL. To evaluate the effect of the inefficient transport of VLDL and LPL-VLDL to the lysosomal compartment on cellular cholesterol homeostasis, acyl-CoA:cholesterol acyltransferase (ACAT) activity was measured. Incubation with 30 micrograms/ml of LDL induced a 2.5-fold increase in ACAT activity, whereas the incubation with similar amounts of both VLDL and LPL-VLDL failed to stimulate this enzyme. We conclude that both a slower transport to the lysosomal compartment and a higher rate of retroendocytosis, possibly as the consequence of the longer residence time in the early endosomes, are responsible for the poor degradation of VLDL and LPL-VLDL by HepG2 cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253728

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Mucolipidosis type IV: abnormal transport of lipids to lysosomes.

Authors:  R Bargal; G Bach
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

2.  Quantitative fluorescence imaging reveals point of release for lipoproteins during LDLR-dependent uptake.

Authors:  Shanica Pompey; Zhenze Zhao; Kate Luby-Phelps; Peter Michaely
Journal:  J Lipid Res       Date:  2013-01-07       Impact factor: 5.922

3.  Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes.

Authors:  F Kuipers; M C Jong; Y Lin; M Eck; R Havinga; V Bloks; H J Verkade; M H Hofker; H Moshage; T J Berkel; R J Vonk; L M Havekes
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

Review 4.  Dissection of the complex role of apolipoprotein E in lipoprotein metabolism and atherosclerosis using mouse models.

Authors:  K W van Dijk; M H Hofker; L M Havekes
Journal:  Curr Atheroscler Rep       Date:  1999-09       Impact factor: 5.113

5.  The epidermal growth factor homology domain of the LDL receptor drives lipoprotein release through an allosteric mechanism involving H190, H562, and H586.

Authors:  Zhenze Zhao; Peter Michaely
Journal:  J Biol Chem       Date:  2008-08-03       Impact factor: 5.157

6.  The role of calcium in lipoprotein release by the low-density lipoprotein receptor.

Authors:  Zhenze Zhao; Peter Michaely
Journal:  Biochemistry       Date:  2009-08-04       Impact factor: 3.162

7.  Identification of a VLDL-induced, FDNPVY-independent internalization mechanism for the LDLR.

Authors:  Peter Michaely; Zhenze Zhao; Wei-Ping Li; Rita Garuti; Lily J Huang; Helen H Hobbs; Jonathan C Cohen
Journal:  EMBO J       Date:  2007-06-21       Impact factor: 11.598

8.  S-nitrosylation of ARH is required for LDL uptake by the LDL receptor.

Authors:  Zhenze Zhao; Shanica Pompey; Hongyun Dong; Jian Weng; Rita Garuti; Peter Michaely
Journal:  J Lipid Res       Date:  2013-04-07       Impact factor: 5.922

Review 9.  Shiga toxins: intracellular trafficking to the ER leading to activation of host cell stress responses.

Authors:  Moo-Seung Lee; Rama P Cherla; Vernon L Tesh
Journal:  Toxins (Basel)       Date:  2010-06-17       Impact factor: 4.546

10.  Wbox2: A clathrin terminal domain-derived peptide inhibitor of clathrin-mediated endocytosis.

Authors:  Zhiming Chen; Rosa E Mino; Marcel Mettlen; Peter Michaely; Madhura Bhave; Dana Kim Reed; Sandra L Schmid
Journal:  J Cell Biol       Date:  2020-09-07       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.